The antioxidant butylated hydroxytoluene protects against atherosclerosis.
- 1 January 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 11 (1), 15-22
- https://doi.org/10.1161/01.atv.11.1.15
Abstract
Rabbits fed a 1% cholesterol diet with or without the antioxidant butylated hydroxytoluene (BHT) developed typical atherosclerotic lesions. The addition of BHT gave higher levels of total cholesterol (+40%), triglycerides (+250%), low density lipoprotein (LDL), and very low density lipoprotein (VLDL) in plasma. Despite the lower plasma lipid levels, the degree of atherosclerosis of the aortic surface was considerably higher in rabbits fed cholesterol than in the group treated with cholesterol and BHT. The mean atherosclerotic involvement was 18.6 +/- 4.4% in the former group and 5.9 +/- 1.7% in the latter group (p = 0.02). In all animals, there was a high correlation between the area of the arterial lesion and cholesterol content (r = 0.96). Serum levels of cholesterol autooxidation products (7-ketocholesterol and cholesterol 5 alpha,6 alpha-epoxide) were lower in the group of rabbits treated with BHT (p less than 0.005). Serum levels of vitamin E were slightly higher in the BHT group. There was no significant difference in the clearance of beta-VLDL between the two treatment groups after using either beta-VLDL from cholesterol-fed animals or beta-VLDL from BHT-fed animals. The results are in accord with the contention that oxidative modification of lipoproteins is important for the development of atherosclerosis and that antioxidants may have a protective effect. At present, however, other explanations cannot be completely excluded, for example, effects of antioxidants on immunologic factors or monocyte adhesion.Keywords
This publication has 27 references indexed in Scilit:
- Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbitEuropean Journal of Clinical Investigation, 1989
- Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- Hyperglycemia in normotriglyceridemic, hypercholesterolemic insulin-treated diabetic rabbits does not accelerate atherogenesisAtherosclerosis, 1988
- Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Severe Hypertriglyceridemia, large lipoproteins and protection against atherosclerosisScandinavian Journal of Clinical and Laboratory Investigation, 1987
- Comparative atherogenic effects of cholesterol and cholesterol oxidesAtherosclerosis, 1986
- Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Lipoprotein fractionation.Journal of Clinical Pathology, 1973